Breaking News Instant updates and real-time market news.

BLMN

Bloomin' Brands

$12.18 /

-0.82 (-6.31%)

08:17
06/11/20
06/11
08:17
06/11/20
08:17

Bloomin' Brands reports weekly U.S. comparable restaurant sales update

Reports week ended May 10 comparable restaurant sales down 42.2%. Reports week ended May 17 comparable restaurant sales down 39.1%. Reports week ended May 24 comparable restaurant sales down 34.7%. Reports week ended May 31 comparable restaurant sales down 29.5%. Reports week ended June 6 comparable restaurant sales down 28.3%.

BLMN Bloomin' Brands
$12.18 /

-0.82 (-6.31%)

05/29/20
Fly Intel: Top five analyst upgrades
05/29/20 Jefferies
Bloomin' Brands upgraded to Buy on early read on reopenings at Jefferies
05/29/20 Jefferies
Bloomin' Brands upgraded to Buy from Hold at Jefferies
05/13/20 Loop Capital
Bloomin' Brands price target lowered to $15 from $27 at Loop Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Pintec Technology announces risk management partnership with ICBC » 21:01
07/06/20
07/06
21:01
07/06/20
21:01
PT

Pintec Technology

$1.28 /

+0.15 (+13.27%)

Pintec Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PT Pintec Technology
$1.28 /

+0.15 (+13.27%)

PT Pintec Technology
$1.28 /

+0.15 (+13.27%)

Upgrade
Acadia upgraded to Buy from Hold at Stifel » 20:31
07/06/20
07/06
20:31
07/06/20
20:31
ACAD

Acadia

$53.60 /

+2.03 (+3.94%)

Stifel analyst Paul…

Stifel analyst Paul Matteis upgraded Acadia to Buy from Hold with a price target of $71, up from $41. The analyst notes that the key opinion leader feedback negates his skepticism on whether primavanserin is "that good of a drug" and is "too good to overlook" in the dementia-related psychosis, or DRP. Matteis adds that the safety argument for prescribing pimavanserin in the DRP population is also "very strong".

ShowHide Related Items >><<
ACAD Acadia
$53.60 /

+2.03 (+3.94%)

ACAD Acadia
$53.60 /

+2.03 (+3.94%)

06/24/20 Citi
Acadia risk/reward skewed to upside into depression data, says Citi
06/23/20 Jefferies
Jefferies sees high odds of positive MDD data from Acadia next month
05/27/20 Oppenheimer
Acadia price target raised to $53 from $48 at Oppenheimer
04/16/20
Fly Intel: Top five analyst initiations
ACAD Acadia
$53.60 /

+2.03 (+3.94%)

  • 18
    Sep
ACAD Acadia
$53.60 /

+2.03 (+3.94%)

ACAD Acadia
$53.60 /

+2.03 (+3.94%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
07/06/20
07/06
20:25
07/06/20
20:25
PAYX

Paychex

$77.84 /

+1.26 (+1.65%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Paychex (PAYX), consensus 60c.

ShowHide Related Items >><<
PAYX Paychex
$77.84 /

+1.26 (+1.65%)

PAYX Paychex
$77.84 /

+1.26 (+1.65%)

05/20/20 Deutsche Bank
Paychex price target lowered to $75 from $80 at Deutsche Bank
05/19/20 Jefferies
Jefferies stays on sidelines of Paychex due to near-term risks
04/29/20 Credit Suisse
TriNet price target raised to $44 from $38 at Credit Suisse
03/26/20 BMO Capital
Paychex price target lowered to $70 from $80 at BMO Capital
PAYX Paychex
$77.84 /

+1.26 (+1.65%)

Upgrade
Arthur J. Gallagher upgraded to Buy from Hold at Deutsche Bank » 20:15
07/06/20
07/06
20:15
07/06/20
20:15
AJG

Arthur J. Gallagher

$96.92 /

-0.36 (-0.37%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

06/22/20 Raymond James
Arthur J. Gallagher price target raised to $110 from $85 at Raymond James
06/18/20 SunTrust
Arthur J. Gallagher price target raised to $118 from $110 at SunTrust
06/18/20 Wells Fargo
Arthur J. Gallagher price target raised to $110 from $101 at Wells Fargo
06/18/20 Deutsche Bank
Arthur J. Gallagher price target raised to $100 from $95 at Deutsche Bank
AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

AJG Arthur J. Gallagher
$96.92 /

-0.36 (-0.37%)

Upgrade
Valmont upgraded to Buy from Hold at Stifel » 20:14
07/06/20
07/06
20:14
07/06/20
20:14
VMI

Valmont

$114.07 /

+0.25 (+0.22%)

Stifel analyst Nathan…

Stifel analyst Nathan Jones upgraded Valmont to Buy from Hold with a price target of $144, up from $128. The analyst is citing his increased confidence that execution issue from the second half of last year are in the past for the company, while the demand in its Utility Support Structures Segment and Engineered Support Structures Segment remains strong. Jones adds that Valmont's Coatings Segment will bottom in Q2 and recover, and that the outlook for its Irrigation Segment - while soft - is still better than feared. The analyst further states that with steel and zinc prices remaining low, the price-to-cost dynamic for the company looks "positive".

ShowHide Related Items >><<
VMI Valmont
$114.07 /

+0.25 (+0.22%)

VMI Valmont
$114.07 /

+0.25 (+0.22%)

04/24/20 DA Davidson
Valmont price target lowered to $125 from $145
02/23/20 Stifel
Valmont Industries downgraded to Hold from Buy at Stifel
02/21/20
Fly Intel: Top five analyst downgrades
02/21/20 DA Davidson
Valmont downgraded to Neutral from Buy at DA Davidson
VMI Valmont
$114.07 /

+0.25 (+0.22%)

Earnings
Samsung sees Q2 operating profit KRW8.10T vs. KRW6.21T consensus » 19:58
07/06/20
07/06
19:58
07/06/20
19:58
SSNLF

Samsung

$0.00 /

+ (+0.00%)

Sees Q2 revenue KRW52.0T…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

13:27 Today Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/19/20 Benchmark
Benchmark says Samsung's NAND chip issues likely positive for HDD makers
04/24/20 Credit Suisse
Apple, Samsung smartphone production plans revised down, says Credit Suisse
03/12/20 KeyBanc
COVID-19 impacting iPhone supply, resulting in lower store traffic, says KeyBanc
SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

Syndicate
Tenax Therapeutics announces $8M registered direct offering » 19:55
07/06/20
07/06
19:55
07/06/20
19:55
TENX

Tenax Therapeutics

$0.91 /

+0.0028 (+0.31%)

Tenax Therapeutics…

Tenax Therapeutics announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale of 2,523,611 shares of its common stock at a purchase price of $1.02780 per share and pre-funded warrants to purchase up to 652,313 shares of common stock, at a purchase price of $1.02770 per pre-funded warrant, in a registered direct offering priced at-the-market under Nasdaq rules. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings.

ShowHide Related Items >><<
TENX Tenax Therapeutics
$0.91 /

+0.0028 (+0.31%)

Hot Stocks
Evolus gets $40M convertible note investment from Daewoong Pharmaceutical Co » 19:54
07/06/20
07/06
19:54
07/06/20
19:54
EOLS

Evolus

$5.33 /

-0.15 (-2.74%)

Evolus announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
05/26/20 Mizuho
Evolus rally Friday has no clear explanation, says Mizuho
05/22/20 Barclays
News from Korea on Medytox has 'no implications' for Evolus, says Barclays
05/22/20 Cantor Fitzgerald
Evolus stock move likely good news, says Cantor Fitzgerald
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

  • 07
    Nov
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

Hot Stocks
Evolus discloses notice of initial determination in Allegan case » 19:53
07/06/20
07/06
19:53
07/06/20
19:53
EOLS

Evolus

$5.33 /

-0.15 (-2.74%)

Evolus announced that the…

Evolus announced that the Administrative Law Judge, or ALJ, overseeing the United States International Trade Commission case filed by Allergan and Medytox in January 2019 against Daewoong and Evolus released a Notice of Initial Determination. This non-binding initial decision by the ALJ finds a violation of Section 337 of the Tariff Act of 1930. The company states: Among the grounds on which Evolus will seek review is that this investigation represents an improper attempt to use the USITC as a means to litigate a dispute between two Korean competitors that is completely disconnected from the United States. The trade secrets asserted by Allergan and its Korean partner Medytox have never been used in the United States. The intellectual property jurisdiction of the USITC was created to protect domestic industries from improper foreign competition. Evolus will petition the full Commission to review this questionable legal maneuvering which would improperly increase the jurisdiction of the USITC beyond the Commission's mandate."

ShowHide Related Items >><<
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
05/26/20 Mizuho
Evolus rally Friday has no clear explanation, says Mizuho
05/22/20 Barclays
News from Korea on Medytox has 'no implications' for Evolus, says Barclays
05/22/20 Cantor Fitzgerald
Evolus stock move likely good news, says Cantor Fitzgerald
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

  • 07
    Nov
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

Hot Stocks
Smart Global's Penguin Computing launches new Tundra AP platform » 19:50
07/06/20
07/06
19:50
07/06/20
19:50
INTC

Intel

$59.51 /

+0.4 (+0.68%)

, SGH

Smart Global

$27.77 /

+0.74 (+2.74%)

Penguin Computing, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

10:06 Today
Fly Intel: Top five analyst downgrades
04:53 Today Goldman Sachs
Intel downgraded to Sell from Neutral at Goldman Sachs
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/23/20 Oppenheimer
Apple creating 'wide moat' for own ecosystem, says Oppenheimer
SGH Smart Global
$27.77 /

+0.74 (+2.74%)

06/05/20 Rosenblatt
Rosenblatt starts 'misunderstood' Smart Global at Buy
06/05/20 Rosenblatt
Smart Global initiated with a Buy at Rosenblatt
04/17/20 Barclays
Smart Global downgraded to Equal Weight on Brazil exposure at Barclays
04/17/20 Barclays
Smart Global downgraded to Equal Weight from Overweight at Barclays
SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

SGH Smart Global
$27.77 /

+0.74 (+2.74%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

INTC Intel
$59.51 /

+0.4 (+0.68%)

Downgrade
ObsEva downgraded to Market Perform from Outperform at BMO Capital » 19:47
07/06/20
07/06
19:47
07/06/20
19:47
OBSV

ObsEva

$3.25 /

-2.9 (-47.15%)

BMO Capital analyst Do…

BMO Capital analyst Do Kim downgraded ObsEva to Market Perform from Outperform with a price target of $4, down from $5, citing "mixed" Linzagolix PRIMROSE 1 results. The analyst notes that the data supports uterine fibroid use approval and his probability of success rises to 85% from 60%, but his estimates for high-dose Linzagolix+ABT use "looks similar to competitors" while being third to market. Kim also pushes out his launch estimate for the treatment by one year "to reflect filing timelines."

ShowHide Related Items >><<
OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

03/24/20 Wedbush
ObsEva price target lowered to $34 from $40 at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 after pipeline update at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 from $36 at Wedbush
12/19/19 H.C. Wainwright
ObsEva price target raised to $40 from $36 at H.C. Wainwright
OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

OBSV ObsEva
$3.25 /

-2.9 (-47.15%)

On The Fly
Fly Intel: After-Hours Movers » 19:08
07/06/20
07/06
19:08
07/06/20
19:08
OTIC

Otonomy

$3.19 /

+0.02 (+0.63%)

, XSPA

XpresSpa

$3.79 /

-0.2 (-5.01%)

, CEMI

Chembio Diagnostics

$4.02 /

-0.15 (-3.60%)

, GLDD

Great Lakes Dredge

$8.85 /

+0.04 (+0.45%)

, PSN

Parsons

$34.56 /

-0.37 (-1.06%)

, KINS

Kingstone Companies

$4.41 /

-0.01 (-0.23%)

, MARK

Remark Holdings

$2.61 /

+0.235 (+9.89%)

, CLLS

Cellectis

$19.04 /

+0.42 (+2.26%)

, TRIB

Trinity Biotech

$2.54 /

+0.23 (+9.96%)

, RVMD

Revolution Medicines

$29.27 /

-1.73 (-5.58%)

, PCRX

Pacira

$54.13 /

+1.93 (+3.70%)

, ARE

Alexandria Real Estate

$164.78 /

-0.08 (-0.05%)

, KMI

Kinder Morgan

$15.20 /

+0.07 (+0.46%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

06/15/20 Piper Sandler
Piper remains optimistic on Otonomy ahead of near-term clinical readouts
06/01/20 Oppenheimer
Otonomy assumed with an Outperform at Oppenheimer
05/07/20 Piper Sandler
Piper still believes in potential success of three key Otonomy programs
02/07/20 Piper Sandler
Otonomy should be bought ahead of near-term readouts, says Piper Sandler
XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

06/17/20
Fly Intel: Top five analyst downgrades
06/17/20 Craig-Hallum
Chembio Diagnostics downgraded to Hold from Buy at Craig-Hallum
06/17/20 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
06/17/20 Canaccord
Chembio Diagnostics downgraded to Hold at Canaccord
GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
KINS Kingstone Companies
$4.41 /

-0.01 (-0.23%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

06/10/20 Roth Capital
Roth checks point to Kent Services as Remark Holdings distribution partner
05/27/20 Roth Capital
Wynn video 'clearly shows' Remark AI technology in use, says Roth Capital
07/15/19 Roth Capital
Sharecare liquidity event would help capitalize Remark AI business, says Roth Capital
CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

05/12/20
Fly Intel: Top five analyst initiations
05/11/20 Baird
Cellectis initiated with an Outperform at Baird
03/06/20 Citi
Cellectis price target raised to $16 from $14 at Citi
03/06/20 Goldman Sachs
Cellectis downgraded to Sell from Neutral at Goldman Sachs
TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
03/09/20 Cowen
Revolution Medicines initiated with an Outperform at Cowen
PCRX Pacira
$54.13 /

+1.93 (+3.70%)

07:47 Today Needham
Pacira price target raised to $64 from $52 at Needham
06:02 Today Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
06/30/20 SVB Leerink
Pacira price target raised to $58 from $45 at SVB Leerink
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

17:51 Today Goldman Sachs
Kinder Morgan downgraded to Sell from Neutral at Goldman Sachs
05/18/20 BofA
Plains All American, GP Holdings cut to Underperform at BofA
04/07/20 Mizuho
Kinder Morgan price target lowered to $20 from $23 at Mizuho
03/24/20 Barclays
Kinder Morgan upgraded to Overweight from Equal Weight at Barclays
TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

KINS Kingstone Companies
$4.41 /

-0.01 (-0.23%)

GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

  • 07
    Jul
  • 09
    Jul
  • 07
    May
  • 13
    Feb
  • 07
    Jan
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

Earnings
Remark Holdings reports Q1 EPS (5c) vs. (23c) last year » 19:00
07/06/20
07/06
19:00
07/06/20
19:00
MARK

Remark Holdings

$2.61 /

+0.235 (+9.89%)

CEO Kai-Shing Tao says:…

CEO Kai-Shing Tao says: "The first quarter of 2020 was one of renewed focus for Remark Holdings as our development team localized our award winning AI-solutions for the U.S. market, and improved our educational thermal scanning product in response to the ongoing COVID-19 pandemic. Our product line of high-quality, highly-effective thermal imaging solutions leverages our innovative software to provide customers with the ability to scan crowds and areas of high foot traffic for indications that certain persons may require secondary screening. We spent much of the quarter on product development and building out our U.S. sales and support team, recently showing initial success with casinos, entertainment complexes, sports venues, restaurants, hospitals and medical centers as well as other industries."

ShowHide Related Items >><<
MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

06/10/20 Roth Capital
Roth checks point to Kent Services as Remark Holdings distribution partner
05/27/20 Roth Capital
Wynn video 'clearly shows' Remark AI technology in use, says Roth Capital
07/15/19 Roth Capital
Sharecare liquidity event would help capitalize Remark AI business, says Roth Capital
MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

Hot Stocks
LGI Homes reports 2,005 home closings in Q2 » 18:49
07/06/20
07/06
18:49
07/06/20
18:49
LGIH

LGI Homes

$92.29 /

+4.39 (+4.99%)

LGI Homes announced 760…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGIH LGI Homes
$92.29 /

+4.39 (+4.99%)

LGIH LGI Homes
$92.29 /

+4.39 (+4.99%)

06/11/20 JPMorgan
PulteGroup upgraded, KB downgraded as JPMorgan adjusts homebuilder ratings
06/11/20 JPMorgan
LGI Homes upgraded to Neutral from Underweight at JPMorgan
06/04/20 Wedbush
LGI Homes downgraded to Neutral at Wedbush
06/04/20 Wedbush
LGI Homes downgraded to Neutral from Outperform at Wedbush
LGIH LGI Homes
$92.29 /

+4.39 (+4.99%)

Periodicals
Sirius XM near deal to acquire Stitcher from Scripps, WSJ reports » 18:46
07/06/20
07/06
18:46
07/06/20
18:46
SIRI

Sirius XM

$5.85 /

+0.01 (+0.17%)

, SSP

E.W. Scripps

$8.40 /

+0.12 (+1.45%)

, SPOT

Spotify

$260.08 /

-11.51 (-4.24%)

, IHRT

iHeartMedia

$7.13 /

-0.05 (-0.70%)

Sirius XM (SIRI) is close…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSP E.W. Scripps
$8.40 /

+0.12 (+1.45%)

SPOT Spotify
$260.08 /

-11.51 (-4.24%)

SIRI Sirius XM
$5.85 /

+0.01 (+0.17%)

IHRT iHeartMedia
$7.13 /

-0.05 (-0.70%)

SIRI Sirius XM
$5.85 /

+0.01 (+0.17%)

06/23/20 B. Riley FBR
Sirius XM estimate raises could drive stock 're-rating,' says B. Riley FBR
06/02/20 JPMorgan
Sirius XM named a top pick for June at JPMorgan
05/19/20 Pivotal Research
Liberty SiriusXM price target lowered to $52 from $63 at Pivotal Research
04/09/20 Barrington
Sirius XM price target lowered to $7.50 from $8.50 at Barrington
SSP E.W. Scripps
$8.40 /

+0.12 (+1.45%)

06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
09/23/19 Wells Fargo
E.W. Scripps initiated with an Outperform at Wells Fargo
SPOT Spotify
$260.08 /

-11.51 (-4.24%)

10:06 Today
Fly Intel: Top five analyst downgrades
06:44 Today JPMorgan
Spotify price target raised to $305 from $185 at JPMorgan
06:16 Today Bernstein
Bernstein doubts Spotify will make money off podcasts, downgrades to sell
05:17 Today Bernstein
Spotify downgraded to Underperform from Market Perform at Bernstein
IHRT iHeartMedia
$7.13 /

-0.05 (-0.70%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
04/23/20 Guggenheim
iHeartMedia price target lowered to $10 from $21.50 at Guggenheim
SSP E.W. Scripps
$8.40 /

+0.12 (+1.45%)

SPOT Spotify
$260.08 /

-11.51 (-4.24%)

SIRI Sirius XM
$5.85 /

+0.01 (+0.17%)

IHRT iHeartMedia
$7.13 /

-0.05 (-0.70%)

  • 22
    Nov
SSP E.W. Scripps
$8.40 /

+0.12 (+1.45%)

SPOT Spotify
$260.08 /

-11.51 (-4.24%)

SIRI Sirius XM
$5.85 /

+0.01 (+0.17%)

SPOT Spotify
$260.08 /

-11.51 (-4.24%)

SIRI Sirius XM
$5.85 /

+0.01 (+0.17%)

IHRT iHeartMedia
$7.13 /

-0.05 (-0.70%)

SPOT Spotify
$260.08 /

-11.51 (-4.24%)

SIRI Sirius XM
$5.85 /

+0.01 (+0.17%)

IHRT iHeartMedia
$7.13 /

-0.05 (-0.70%)

Periodicals
Blackstone seeks $7.5B for fourth subordinated debt vehicle, Reuters says » 18:21
07/06/20
07/06
18:21
07/06/20
18:21
BX

Blackstone

$55.32 /

-0.085 (-0.15%)

Blackstone's credit…

Blackstone's credit business GSO Capital is eyeing $7.5B for its fourth subordinated debt vehicle, Reuters' Andrew Hedlund reports, citing investor notes from the Teachers' Retirement System of Louisiana. The asset manager rolled out its GSO Capital Opportunities Fund IV, which is eyeing surpassed the $6.5B raised by its predecessor, the author notes. Reference Link

ShowHide Related Items >><<
BX Blackstone
$55.32 /

-0.085 (-0.15%)

BX Blackstone
$55.32 /

-0.085 (-0.15%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BX Blackstone
$55.32 /

-0.085 (-0.15%)

BX Blackstone
$55.32 /

-0.085 (-0.15%)

BX Blackstone
$55.32 /

-0.085 (-0.15%)

BX Blackstone
$55.32 /

-0.085 (-0.15%)

Hot Stocks
Norbord says North American mills produced at 74% of capacity in Q2 » 18:21
07/06/20
07/06
18:21
07/06/20
18:21
OSB

Norbord

$24.00 /

+0.55 (+2.35%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSB Norbord
$24.00 /

+0.55 (+2.35%)

OSB Norbord
$24.00 /

+0.55 (+2.35%)

13:28 Today CIBC
Norbord price target raised to C$45 from C$37 at CIBC
06/15/20 CIBC
Norbord price target raised to C$37 from C$34 at CIBC
05/07/20 TD Securities
Norbord downgraded to Buy after rally at TD Securities
05/07/20 TD Securities
Norbord downgraded to Buy from Action List Buy at TD Securities
OSB Norbord
$24.00 /

+0.55 (+2.35%)

Periodicals
German prosecutors arrest Wirecard's Dubai subsidiary chief, Reuters says » 18:18
07/06/20
07/06
18:18
07/06/20
18:18
WCAGY

Wirecard

$0.00 /

+ (+0.00%)

German prosecutors said…

German prosecutors said that they have arrested the head of Wirecard's Dubai-based business, broadening the list of suspects in a multi-billion-dollar fraud probe into the collapse of the payments company, Reuters' Douglas Busvine and Arno Schuetze report. The Munich prosecutor's office said it questioned the CEO of Cardsystems Middle East FZ-LLC earlier in the day and arrested the man on the basis of a warrant, the authors say. The individual had traveled from Dubai and turned himself in, the authors note. Reference Link

ShowHide Related Items >><<
WCAGY Wirecard
$0.00 /

+ (+0.00%)

WCAGY Wirecard
$0.00 /

+ (+0.00%)

06/24/20 BofA
Wirecard price target lowered to EUR 1 from EUR 14 at BofA
06/19/20 Oddo BHF
Wirecard downgraded to Reduce from Neutral at Oddo BHF
06/19/20 Bryan Garnier
Wirecard downgraded to Sell from Buy at Bryan Garnier
06/18/20 Jefferies
Network International may benefit from Wirecard troubles, says Jefferies
WCAGY Wirecard
$0.00 /

+ (+0.00%)

Upgrade
TC PipeLines upgraded to Neutral from Sell at Goldman Sachs » 18:02
07/06/20
07/06
18:02
07/06/20
18:02
TCP

TC PipeLines

$30.33 /

-0.2 (-0.66%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCP TC PipeLines
$30.33 /

-0.2 (-0.66%)

06/19/20 Citi
TC PipeLines price target lowered to $35 from $40 at Citi
05/12/20
Fly Intel: Top five analyst initiations
05/12/20 Jefferies
TC PipeLines initiated with a Buy at Jefferies
04/15/20 JPMorgan
JPMorgan double upgrades TC PipeLines to Overweight from Underweight
TCP TC PipeLines
$30.33 /

-0.2 (-0.66%)

Downgrade
Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs » 17:55
07/06/20
07/06
17:55
07/06/20
17:55
RTLR

Rattler Midstream

$9.61 /

+0.11 (+1.16%)

, FANG

Diamondback Energy

$42.95 /

+1.39 (+3.34%)

, XLE

Energy Select Sector SPDR

$37.46 /

+0.14 (+0.38%)

Goldman Sachs analyst…

Goldman Sachs analyst Michael Lapides downgraded Rattler Midstream to Neutral from Buy with an unchanged $10 price target. The units have materially outperformed the Midstream Energy AMNA index as well as the broader energy sector ETF XLE since the March 18th trough, but the stock warrants a discount multiple because of its exposure to largely one customer - Diamond Back Energy (FANG) - the analyst tells investors in a research note.

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$37.46 /

+0.14 (+0.38%)

RTLR Rattler Midstream
$9.61 /

+0.11 (+1.16%)

FANG Diamondback Energy
$42.95 /

+1.39 (+3.34%)

RTLR Rattler Midstream
$9.61 /

+0.11 (+1.16%)

04/29/20 Capital One
Rattler Midstream downgraded to Equalweight from Overweight at Capital One
03/16/20 RBC Capital
RBC Capital cuts select Energy names on leverage, counterparty concerns
03/16/20 RBC Capital
Rattler Midstream upgraded to Outperform from Sector Perform at RBC Capital
03/12/20 Raymond James
Rattler Midstream downgraded to Market Perform from Outperform at Raymond James
FANG Diamondback Energy
$42.95 /

+1.39 (+3.34%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/29/20 BMO Capital
Diamondback Energy downgraded to Market Perform from Outperform at BMO Capital
06/25/20
Diamondback Energy upgraded to Buy at SunTrust on improved cash flow outlook
06/25/20 SunTrust
Diamondback Energy upgraded to Buy from Hold at SunTrust
XLE Energy Select Sector SPDR
$37.46 /

+0.14 (+0.38%)

RTLR Rattler Midstream
$9.61 /

+0.11 (+1.16%)

FANG Diamondback Energy
$42.95 /

+1.39 (+3.34%)

XLE Energy Select Sector SPDR
$37.46 /

+0.14 (+0.38%)

FANG Diamondback Energy
$42.95 /

+1.39 (+3.34%)

RTLR Rattler Midstream
$9.61 /

+0.11 (+1.16%)

FANG Diamondback Energy
$42.95 /

+1.39 (+3.34%)

XLE Energy Select Sector SPDR
$37.46 /

+0.14 (+0.38%)

FANG Diamondback Energy
$42.95 /

+1.39 (+3.34%)

XLE Energy Select Sector SPDR
$37.46 /

+0.14 (+0.38%)

Downgrade
Kinder Morgan downgraded to Sell from Neutral at Goldman Sachs » 17:51
07/06/20
07/06
17:51
07/06/20
17:51
KMI

Kinder Morgan

$15.20 /

+0.07 (+0.46%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

05/18/20 BofA
Plains All American, GP Holdings cut to Underperform at BofA
04/07/20 Mizuho
Kinder Morgan price target lowered to $20 from $23 at Mizuho
03/24/20 Barclays
Kinder Morgan upgraded to Overweight from Equal Weight at Barclays
03/16/20 Morgan Stanley
Morgan Stanley shakes up Midstream ratings in expectation of continued pressure
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

Hot Stocks
ATIF Holdings reports 6.6% active stake in AeroCentury » 17:44
07/06/20
07/06
17:44
07/06/20
17:44
ACY

AeroCentury

$2.65 /

-0.215 (-7.50%)

, ATIF

ATIF Holdings

$1.95 /

+0.03 (+1.56%)

"ATIF Holdings(ATIF)…

"ATIF Holdings(ATIF) expended an aggregate of approximately $284,217.52 to acquire 101,367 shares of Common Stock of the AeroCentury (ACY) in various open market transactions. ATIF Holdings used its personal funds to acquire the shares of Common Stock of AeroCentury," said the company in a filing.

ShowHide Related Items >><<
ATIF ATIF Holdings
$1.95 /

+0.03 (+1.56%)

Hot Stocks
RBC seeks to increase percentage of BIPOC executives to 30% from 20% » 17:42
07/06/20
07/06
17:42
07/06/20
17:42
RY

Royal Bank of Canada

$68.97 /

+0.81 (+1.19%)

The Royal Bank of Canda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RY Royal Bank of Canada
$68.97 /

+0.81 (+1.19%)

RY Royal Bank of Canada
$68.97 /

+0.81 (+1.19%)

05/28/20 BMO Capital
Royal Bank of Canada price target raised to C$93 from C$90 at BMO Capital
05/28/20 Scotiabank
Royal Bank of Canada price target raised to C$105 from C$97 at Scotiabank
05/28/20 Canaccord
Royal Bank of Canada price target raised to C$95 from C$86.50 at Canaccord
05/22/20 Scotiabank
Royal Bank of Canada price target lowered to C$97 from C$99 at Scotiabank
RY Royal Bank of Canada
$68.97 /

+0.81 (+1.19%)

RY Royal Bank of Canada
$68.97 /

+0.81 (+1.19%)

RY Royal Bank of Canada
$68.97 /

+0.81 (+1.19%)

Syndicate
Tufin files $100M mixed securities shelf  17:33
07/06/20
07/06
17:33
07/06/20
17:33
TUFN

Tufin

$10.07 /

+0.34 (+3.49%)

 
ShowHide Related Items >><<
TUFN Tufin
$10.07 /

+0.34 (+3.49%)

TUFN Tufin
$10.07 /

+0.34 (+3.49%)

06/23/20 Barclays
Barclays downgrades 'show-me' story Tufin to Equal Weight
06/23/20 Barclays
Tufin downgraded to Equal Weight from Overweight at Barclays
05/13/20 Jefferies
Tufin downgraded to Hold from Buy at Jefferies
03/27/20
Tufin initiated with a Buy at Dougherty
TUFN Tufin
$10.07 /

+0.34 (+3.49%)

  • 05
    Dec
Hot Stocks
New Mountain reports 10.78% activist stake in Virtusa, board nominees » 17:28
07/06/20
07/06
17:28
07/06/20
17:28
VRTU

Virtusa

$31.51 /

-0.45 (-1.41%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTU Virtusa
$31.51 /

-0.45 (-1.41%)

VRTU Virtusa
$31.51 /

-0.45 (-1.41%)

05/14/20 William Blair
Virtusa downgraded to Market Perform from Outperform at William Blair
02/07/20 Needham
Virtusa price target raised to $56 from $48 at Needham
01/07/20 Barrington
Adtalem, Tivity, Virtusa among Barrington's Best Ideas for 2020
01/06/20 Wedbush
Wedbush says buy Virtusa on weakness as market 'overreacts' to Citi renewal
VRTU Virtusa
$31.51 /

-0.45 (-1.41%)

VRTU Virtusa
$31.51 /

-0.45 (-1.41%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.